Investor profile
Alta Life Sciences has backed 5 European tech companies across 7 funding rounds between 2018 and 2026, joining rounds totalling €109M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Ona Therapeutics | Spain | 1 | €74M |
| Deepull | Spain | 3 | €19M |
| Accure Therapeutics | Spain | 1 | €7.6M |
| Peptomyc | Spain | 1 | €5.0M |
| Mediktor | Spain |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Ona Therapeutics | Series B | €74M | 2026-06 |
| Deepull | Series B | €13M | 2022-10 |
| Accure Therapeutics | Series A | €7.6M | 2020-05 |
| Peptomyc |
| 1 |
| €3.0M |
| Other |
| €5.0M |
| 2026-04 |
| Deepull | Series A | €3.5M | 2020-07 |
| Mediktor | Series A | €3.0M | 2018-12 |
| Deepull | Other | €2.3M | 2022-11 |
